Flatiron Health emphasizes its contribution to global real‑world evidence and HTA methods

Flatiron Health released a statement on its involvement in real‑world evidence generation. The company outlined how its data platforms support health technology assessments worldwide. Executives noted collaborations with regulators and payers to inform decision‑making. Flatiron’s oncology datasets were cited as examples of actionable evidence. The firm stressed the importance of standardized methodology for HTA processes. Partnerships with research institutions were highlighted as part of the effort. The announcement underscores Flatiron’s role in shaping evidence‑based care. Stakeholders are invited to engage in upcoming workshops on the topic.